Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt

    • Product Name 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt
    • Alias dCTP
    • Einecs 242-940-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    321855

    Product Name 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt
    Synonyms dCTP disodium salt
    Molecular Formula C9H15N3O13P3Na2
    Cas Number 102783-51-7
    Purity ≥95%
    Appearance White to off-white powder
    Storage Temperature -20°C
    Solubility Water soluble
    Usage Biochemical research, primarily for DNA synthesis
    Stability Stable when stored at -20°C, protected from light and moisture
    Identifiers PubChem CID: 22832925

    As an accredited 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical is packaged in a 25 mg amber glass vial, sealed under inert gas, with tamper-evident labeling and detailed product information.
    Shipping 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt is shipped in tightly sealed, protective containers under dry, cool conditions. For optimal stability, it is typically packed with ice packs or dry ice, ensuring low temperatures during transit. All shipments are compliant with relevant chemical transport regulations for laboratory research chemicals.
    Storage 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt should be stored at -20°C, protected from light and moisture. The container must be tightly sealed to prevent degradation. Avoid repeated freeze-thaw cycles to maintain chemical stability. Store in a dry, well-ventilated area, away from incompatible substances, and follow all relevant safety protocols for handling sensitive nucleotides.
    Application of 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt

    Applications of 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt in Industrial Manufacturing

    2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt enables key downstream biotechnological, diagnostic, and pharmaceutical processes. Our manufacturing expertise supports critical sectors relying on its unique biochemical attributes as a DNA building block.

    1. Nucleic Acid Amplification Reagent Production

    This material plays a central role in nucleotide mix formulations for industrial-scale PCR and qPCR reagent manufacturing. Direct incorporation during enzymatic assembly ensures high-purity and lot-to-lot consistency vital for downstream assay reproducibility and regulatory review.

    Industry compliance standards

    • ISO 13485 for in vitro diagnostic (IVD) reagent manufacturing
    • FDA 21 CFR Part 820 for medical device components
    • IVDR (EU Regulation 2017/746) compliance for European markets
    • Chinese YY/T 1022-2021 for nucleic acid diagnostic reagents

    Typical usage ratio

    • 0.2–2 mM final concentration in PCR/qPCR mixes, adjusted by enzyme type and template complexity
    • Balanced alongside dATP, dGTP, and dTTP in equimolar or adjusted pools as dictated by downstream primer sequences

    Downstream process integration

    • Dissolved directly into buffer with other nucleotide triphosphates post-purification
    • Undergoes sterile filtration prior to enzymatic reagent assembly
    • Added during final blend formation for lyophilized or liquid formulations
    • Subjected to batch QC for nucleotide purity and contaminant profile

    Final product types

    • PCR and qPCR master mixes (bulk and OEM packaging)
    • Isothermal amplification kits
    • DNA library preparation reagents for sequencing platforms
    • Clinical and research diagnostic IVD kits

    2. Antiviral Nucleoside Analog Synthesis

    Nucleoside triphosphate supplies the precursor needed for chemical derivatization steps in industrial synthesis of deoxycytidine-based antiviral pharmaceuticals. Controlled incorporation safeguards downstream impurity levels and reaction yields across multi-stage organic synthesis lines.

    Industry compliance standards

    • ICH Q7A GMP for active pharmaceutical ingredients (API)
    • USP–NF monographs for nucleoside derivatives
    • European Pharmacopoeia 10.0 (2.2.46 Nucleoside triphosphates)
    • FDA DMF submission requirements

    Typical usage ratio

    • Stoichiometric: 1–1.2 equivalents per downstream coupling reaction
    • Adjusted according to target analog conversion rates and product assay

    Downstream process integration

    • Loaded into anhydrous organic phase or salt-exchanged buffer for selective modification
    • Enters reactor charge as an initial substrate or intermediate
    • Used in phosphorylation/de-phosphorylation cycling steps
    • Subjected to in-process HPLC monitoring

    Final product types

    • API-grade cytidine analogs (e.g., Cidofovir, Gemcitabine derivatives)
    • Antiviral finished drug substances
    • Solid form pharmaceutical intermediates
    • Bulk intermediates for later formulation

    3. DNA Sequencing Kit Manufacturing

    High-purity 2’-deoxycytidine triphosphate enters the fluorescently tagged sequencing reaction cocktail, directly impacting signal fidelity. Strict specification during blending and QC aligns with regulatory and instrument manufacturer requirements for end-use genomic analysis systems.

    Industry compliance standards

    • ISO 9001:2015 for quality management
    • ISO 18385:2016 for minimizing human DNA contamination in forensic workflow
    • CLSI MM17 for DNA sequencing quality assurance
    • REACH Regulation (EC) No 1907/2006 for EU market distribution

    Typical usage ratio

    • 30–50 μM for Sanger sequencing reactions per manufacturer's protocol
    • Equimolar with fluorescent or dye-terminator substrates depending on assay type
    • Ratio adjusted for high-GC or low-complexity templates up to 100 μM

    Downstream process integration

    • Added to master mix base during automated compounding
    • Subjected to cross-contamination testing before aliquoting
    • QC for nucleotide identity, concentration, and UV purity prior to kit fill
    • Stabilized in ready-to-use or lyophilized forms as per OEM/ODM requirement

    Final product types

    • Sanger sequencing kits for laboratory and clinical markets
    • Next-generation sequencing (NGS) DNA prep reagents
    • Capillary electrophoresis DNA analysis kits
    • Forensics and ancestry testing solutions

    4. In Vitro Transcription (IVT) and Synthetic Biology

    As a nucleotide substrate, this product forms a key raw material for mRNA and antisense oligonucleotide synthesis. Downstream formulation demands consistent triphosphate content to guarantee transcript yield and homogeneity, especially in cGMP RNA drug production and gene circuit assembly.

    Industry compliance standards

    • USP General Chapter <1237> for gene therapy and oligonucleotide APIs
    • U.S. FDA cGMP (21 CFR Part 210, 211)
    • EMA Guidelines for Advanced Therapy Medicinal Products (ATMPs)
    • Ph. Eur. 10.0 monograph for oligonucleotides

    Typical usage ratio

    • Standard IVT: 1–10 mM in enzymatic transcription systems, subject to enzyme lot and full nucleotide mix balancing
    • Adjusted for capped/methylated mRNA by enzyme and output titer target

    Downstream process integration

    • Fed into RNA polymerase reaction chamber as in-line fed-batch substrate
    • Preformulated with other NTPs for high-throughput oligonucleotide synthesizers
    • Subjected to in-process monitoring and post-synthesis chromatographic purification
    • QC for pyrogenicity and identity before release for drug substance integration

    Final product types

    • Synthetic mRNA for vaccines and therapeutics
    • Custom long- and short-strand RNA products
    • Oligonucleotide APIs for gene knockdown therapies
    • Biomanufactured genetic circuits for synthetic biology startups
    Free Quote

    Competitive 2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    2'-Deoxycytidine-5'-Triphosphoric Acid Disodium Salt: A Closer Look from the Manufacturer’s Bench

    Genuine Production Experience in Nucleotide Manufacturing

    Standing in front of a reaction vessel watching 2'-Deoxycytidine-5'-Triphosphoric Acid disodium salt reach completion, there’s a certain satisfaction after a multi-stage nucleotide synthesis comes together. As a manufacturer, we do not simply receive drums from an upstream supplier and pass on a COA—we see every stage, from raw cytidine materials to high-resolution purification, under our direct supervision. It is this deep process involvement that gives us perspective on how and why 2'-Deoxycytidine-5'-Triphosphoric Acid disodium salt offers more than chemical formulae on paper.

    Clear Nomenclature, Real Sample

    Chemists and researchers refer to this material simply as dCTP, but there’s nothing simple about working with it at the level of purity and consistency required for life science projects. In our practice, we focus on the crystalline disodium salt form—well-suited for aqueous-based enzymatic reactions, free of contaminants that would interfere with DNA synthesis or amplification work. Our standard offering—model dCTP-Na2—comes with a defined purity above 98 percent based on HPLC analysis. We check for trace metals, residual organic volatiles, and screen for pyrogens, all as part of our approach to producing a trusted molecular building block.

    What Sets dCTP Disodium Salt Apart in Synthesis

    Many labs know dCTP as a familiar name paired with other deoxynucleotide triphosphates when assembling PCR mixes or when sequencing DNA. But in manufacturing, details matter. The stability and solubility of the disodium salt brings some everyday ease to both biochemical workflows and the shelf life of your stocks. This version of dCTP resists hydrolysis better than mono- or free acid forms under repeated freeze-thaw cycles—essential in high-throughput settings where open-close cycles in cold rooms can otherwise degrade lab reagents.

    A lot of customers ask what makes this dCTP stand out from other triphosphates in practice. We have run side-by-side thermostability and impurity degradation tests in actual polymerase chain reactions and extension assays. The difference emerged in the consistent, bright banding of DNA on agarose gels, especially over repeated usage. We found nucleases are not particularly forgiving; minor impurities or microgram-level metal contamination can suppress yields in a way suppliers who only repackage bulk dCTP might overlook. Taking sample after sample through the same thermal cycling, pure dCTP-Na2 from our reactors supports the same high incorporation rates, week after week, batch after batch.

    Specifications with a Purpose—Not Just Numbers

    It’s common for competitors to advertise high purity or “molecular biology grade”—terms that, without regular testing and documentation, lose their meaning. We use a combination of HPLC, nucleoside-specific mass spectrometry, and phosphorus chemistry to confirm the structure, salt form, and absence of hydrolysis products. Each batch we release has to clear tight thresholds not only for purity, but for sodium counterion content—the two sodium ions in the chemical name are not decorative. If sodium is off, the behavior of dCTP in PCR and other amplification protocols shifts, affecting final product quality for researchers who rely on consistent ionic strength.

    Our experience shows how critical even tiny variables are when scaling dCTP for commercial kits or high-throughput screening projects. The product comes as a white crystalline powder, free-flowing and quick-dissolving in water or buffer. For users who need ready-to-go solutions, we provide custom concentrations in nuclease-free water, calibrated against our in-house reference material. Each lot keeps a documented lineage for traceability and may be further tested for specific application requests—sequencing-grade, diagnostic-grade, or for GMP settings.

    Putting dCTP to Work—Beyond the Basic Literature

    2'-Deoxycytidine-5'-Triphosphoric Acid disodium salt is most often recognized as one of four deoxynucleotide triphosphates for DNA polymerization. Yet, working as a supplier deeply embedded in life science workflows, we have tracked its use far beyond basic PCR. Our manufacturing partners report uses in next-generation sequencing sample prep, qPCR diagnostics, DNA labeling, and in vitro transcription-translation systems. A pure and stable dCTP is no longer a luxury in these contexts—cross-contamination or degradation results in reproducibility problems that can impact not just a single experiment, but entire product launches or clinical test development.

    Polymerases, reverse transcriptases, and other enzymes interact with nucleotide substrates at the millimolar to micromolar range. Impurities, especially breakdown products or trace metallic impurities, throw off reaction kinetics in sensitive enzyme assays. As a hands-on producer, our protocols include batch-to-batch enzyme reactivity checks, using standard Taq, high-fidelity polymerases, and select mutant enzymes. Many customers never see this part of the process, but our in-house QC has flagged impurities missed by ordinary chemical testing. Experience with off-spec batches pushed us to upgrade downstream purification, including pre-chromatographic treatments and ion-exchange chromatography, steps that add time but solve real-life problems: ambiguous bands on gels, drop-offs in qPCR efficiency, or unexplained lot-to-lot variability.

    Differences from Other Nucleotides and Commercial Blends

    As manufacturers, we frequently answer questions about the differences between dCTP and the other three canonical triphosphates—dATP, dGTP, and dTTP—in both chemistry and handling. In daily production, dCTP carries the cytosine base, which inherently brings a different risk profile for oxidative degradation and trace impurity carryover, compared to purine-based dATP and dGTP. Our experience tracks that dCTP, more than its purine counterparts, is vulnerable to minute residual water, both in the bulk powder and during handling. To control this, our environment maintains strictly managed humidity and low temperature through every stage, and all end containers include desiccants. Small missteps here cause clumping or hydrolysis that only become visible weeks after the product is shipped.

    There’s a trend among some non-manufacturing resellers to offer “mixes” of all four nucleotides, but these do not allow for custom concentration control or solvents as pure as demanded by researchers in synthetic biology. We have handled feedback from labs who received a mixture packed by third-parties, only to discover skewed dCTP content after routine qPCR failed. We avoid pre-mixed blends to allow full control, either in your own pipetting or by special request under strictly-monitored filling lines.

    Upstream and Downstream—Managing the Process, Not Just the Supply Chain

    Direct control over every stage of 2’-Deoxycytidine-5’-Triphosphoric Acid disodium salt production means keeping a close eye on raw cytidine sources. Impurities from fermentation-based raw materials can linger through early synthetic steps and only emerge as problematic byproducts later. We audit each lot’s impurity profile before committing to scale-up. This ensures the triphosphorylation step—always a delicate part of the process—runs with the correct starting profile and doesn’t introduce variability downstream. These hands-on controls make a difference at larger scales, especially once kilogram-level batches are being run for diagnostic kit production or for contract manufacturing organizations where each shift in impurity level means a phone call from a frustrated customer.

    After synthesis, we take extra steps in filtration, buffer exchange, and ion-exchange purification. Unlike simple precipitation and drying, this sequence strips away nucleoside and phosphate fragments. It’s in these steps that the experience of doing, rather than just reselling, shapes the material’s final usability. Many non-producer vendors lack the equipment to confirm absolute absence of contamination. We see requests for “pyrogen-free” material ramp up as more customers use dCTP in direct-contact diagnostic devices, so every lot receives an endotoxin test along with the regular panel of analyses.

    Quality Assurance from Documentation to Real-World Use

    Each batch of dCTP-Na2 leaving our site carries a certificate of analysis, but the real confidence comes from the transparency of our process notes and openness to scrutiny. We have responded to requests for comprehensive data packages for regulatory filings and for GMP-level documentation, and we are familiar with extending analytical data sets when researchers encounter anomalies in their own workflows. Feedback from users leads directly to revisiting and tightening our in-house test panels, not only for documentation compliance but to answer to colleagues depending on reproducibility at the lab bench.

    Our staff consult on application challenges, from unusual pH requirements for specific polymerases to formulation stability for lyophilized diagnostic kits. The conversations we have with partners drive our process improvements. One case saw a spike in requests for greater-temperature stability in lyophilized formulations, which led to additional pilot studies comparing anhydrous packaging versus standard vials. The result: a second packaging line built to deliver material in both vacuum-sealed and standard forms, all from the same synthesis backbone but custom-finished on request. These adaptations spring from lived production and close communication, not theoretical product management.

    Meeting the Needs of Life Science and Diagnostics Innovation

    R&D timelines in diagnostics and genomics grow shorter each year, with speed-to-market often depending on the reliability of the building blocks used. Our hands-on approach to manufacturing dCTP-Na2 means customers can expect product consistency year-round, with documented controls against batch drift and unexpected changeover between lots. Many of our contracts with biotech companies include pre-market release evaluation by end users, a step driven by mutual understanding: every missed reaction or failed sequencing run wastes not only material but pulls back critical project deadlines.

    Emerging fields such as CRISPR gene editing and nucleic acid amplification diagnostics lean heavily on the availability of reliable triphosphates, with dCTP being essential for tailored polymerase blends or synthetic nucleic acid constructs. We provide material to projects ranging from academic screen developments to high-throughput commercial applications, integrating their feedback into our update cycles. Where other suppliers rely on imported specifications and simple COA paperwork, we keep open books and hands-on technical support, building our quality culture from the bottom up.

    Looking Forward—Investing in Continuous Improvement

    Building a reputation with researchers and production partners for 2'-Deoxycytidine-5'-Triphosphoric Acid disodium salt doesn’t happen in a vacuum. New analytical requirements push us to continually improve in response to both external standards and feedback from real users. Our investment in high-throughput chromatography, improved automations in phosphate loading and quenching, and staff training all boost reliability. As upstream synthetic methods become more refined—especially in green chemistry options—we are exploring enzyme-based phosphorylation techniques, aiming for more environmentally friendly production without sacrificing material reliability.

    We have seen researchers pushing for lower residual solvent content, better-defined counterion ratios, and even higher-purity levels for specialized enzyme work. Tightening these controls, especially for diagnostic applications demanding CLIA or ISO compliance, calls for not just technical upgrades but willingness to customize and respond fast. As a producer, our role isn’t just to ship product but to support the breakthroughs our reagents empower, reducing troubleshooting time for scientists and manufacturers alike.

    Care for Every Granule, Every Batch

    In summary, the real differentiator for dCTP-Na2 lies not just in its molecular formula, but in the practical attention paid to producing, testing, and packaging it. Each lot starts at the source, processed with vigilance, checked against stringent internal and external criteria, and released with full transparency. This hands-on, production-oriented approach, developed through years at the bench and on the plant floor, continues to earn trust among researchers looking for reliability, not just numbers in a product spec. Every request from our partners—be it unusual concentration, special packaging, or deeper impurity profiling—adds knowledge to our process, improving each run for those who will use the material where it counts. True quality arises not from marketing claims, but from the day-to-day work that goes into every shipment.